iDNA Genomics Public (CYS:IDNA) Research & Development: € Mil (TTM As of . 20)


CYS:IDNA iDNA Genomics Public Ltd CYS:IDNA
23 GF Score
Price €22.80
! 2 Warning Signs
View Full Analysis

What is iDNA Genomics Public Research & Development?

iDNA Genomics Public CYS:IDNA 23 Research & Development is € Mil as of . 20. GuruFocus rates CYS:IDNA with a GF Score™ of 23/100. The stock has 2 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. iDNA Genomics Public's Research & Development for the six months ended in . 20 was €0.00 Mil. iDNA Genomics Public does not have enough years/quarters to calculate the Research & Development for the trailing twelve months (TTM) ended in . 20.

iDNA Genomics Public  (CYS:IDNA) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

iDNA Genomics Public Research & Development Related Terms

iDNA Genomics Public Research & Development Historical Data

* Premium members only.

The historical data trend for iDNA Genomics Public's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

iDNA Genomics Public Research & Development Chart

iDNA Genomics Public Annual Data
Trend
Research & Development

iDNA Genomics Public Semi-Annual Data
Research & Development
CYS:IDNA
23GF Score
iDNA Genomics Public Ltd CYS:IDNA
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

iDNA Genomics Public Research & Development Calculation

This is the expense the company spent on research and development.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of € Mil mean?
iDNA Genomics Public (CYS:IDNA) has a Research & Development of € Mil as of . 20. Research and development expense is the total cost for research and development activities. View historical data on iDNA Genomics Public and its competitors.
Is iDNA Genomics Public's Research & Development too high?
iDNA Genomics Public's current Research & Development is € Mil. Overall, iDNA Genomics Public has a GF Score™ of 23/100, reflecting its overall financial health beyond just this single metric.
How does iDNA Genomics Public's Research & Development compare to ?
iDNA Genomics Public's Research & Development of € Mil can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Medical Diagnostics & Research company?
A good Research & Development depends on the Medical Diagnostics & Research industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on iDNA Genomics Public and its competitors. iDNA Genomics Public's current Research & Development is € Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is iDNA Genomics Public stock overvalued right now?
iDNA Genomics Public (CYS:IDNA) has a current Research & Development of € Mil. The current Research & Development is € Mil. iDNA Genomics Public's overall GF Score™ is 23/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For iDNA Genomics Public (CYS:IDNA), the current Research & Development is € Mil as of . 20. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

iDNA Genomics Public Business Description

Comparable Companies
Address 7 Hatzidaki Street, Trypiotis, Nicosia, CYP, 1066
iDNA Genomics Public Ltd operates in the field of genomics and biotechnology and specializes in personalized health care. Its purpose is to develop and provide genetic tests in the field of genomics, through professionals (Medical Genomics) and directly to the consumer (Direct-to-Consumer Genomics).
23GF Score

Get the complete analysis for CYS:IDNA

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€22.80
Price